Skip to main content

Table 4 HDL-C (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

 

Argicolina

Normolip

Argicolina − Normolip

At start of treatment

56.3 ± 15.6

56.6 ± 16.0

−0.3 (−2.9  +2.3)

At end of treatment

57.7 ± 15.3

59.2 ± 17.1*

−1.5 (−3.5  +0.5)

Δ Final–Initial

+1.4 (−0.7  +3.5)

+2.6 (+0.8  +4.3)

−1.2 (−3.8  +1.4)

% Δ(Final–Initial) / Initial

+3.0 (−1.3  +7.3)

+4.3 (+1.5  +7.1)

−1.3 (−6.0  +3.3)

  1. Data are expressed as mean ± SD, (95%CI), and analyzed by Student’s t test for paired data (end vs. start of treatment), * p < 0.01